Product Program year 2024 Source: CMS Open Payments

Scopesafelaser Fiber

Device Urology

PDI B14527750200U10

Open in the dashboard

General payments

$27,216

20 payments

Research payments

$0

0 payments

Through program year 2024, $27,216 in general payments and $0 in research payments were reported against Scopesafelaser Fiber (Urology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2024 General $20,434 6
2023 General $6,782 14

Breakdown

Who paid General payments · program years 2023–2024
  1. KARL STORZ Endoscopy-America $26,863 19 payments
  2. Karl Storz Imaging, Inc. $353 1 payment
Top recipients General payments · program year 2024
  1. Ilya Sobol Urology · Virginia Beach, VA $14,424 71% · 4 payments
  2. Casey Dauw Urology · Ann Arbor, MI $4,960 24% · 1 payment
  3. Kymora Scotland Urology · Los Angeles, CA $1,050 5% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Urology $20,434 100% · 3 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Virginia $14,424 71% · 1 recipient
  2. Michigan $4,960 24% · 1 recipient
  3. California $1,050 5% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

20 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record